165 related articles for article (PubMed ID: 30805395)
1. Increasing Cellular Immune Response in Liposomal Formulations of DOTAP Encapsulated by Fusion Protein Hspx, PPE44, And Esxv, as a Potential Tuberculosis Vaccine Candidate.
Mansury D; Ghazvini K; Amel Jamehdar S; Badiee A; Tafaghodi M; Nikpoor AR; Amini Y; Jaafari MR
Rep Biochem Mol Biol; 2019 Jan; 7(2):156-166. PubMed ID: 30805395
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV.
Mansury D; Ghazvini K; Amel Jamehdar S; Badiee A; Tafaghodi M; Nikpoor AR; Amini Y; Jaafari MR
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):370-377. PubMed ID: 30691310
[TBL] [Abstract][Full Text] [Related]
3. Chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for
Hoseinpur R; Hasani A; Baradaran B; Abdolalizadeh J; Amini Y; Salehi R; Samadi Kafil H; Azizian K; Memar MY; Gholizadeh P; Hasani A
J Biomater Appl; 2022 Jul; 37(1):40-47. PubMed ID: 35430919
[TBL] [Abstract][Full Text] [Related]
4. A new DNA vaccine expressing HspX-PPE44-EsxV fusion antigens of
Moradi B; Sankian M; Amini Y; Gholoobi A; Meshkat Z
Iran J Basic Med Sci; 2020 Jul; 23(7):909-914. PubMed ID: 32774813
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Immune Response against Leishmaniasis in BALB/c Mice Immunized with Cationic DOTAP/DOPE/CHOL Liposomes Containing Soluble
Hojatizade M; Badiee A; Khamesipour A; Jaafari MR
Iran J Parasitol; 2019; 14(1):68-77. PubMed ID: 31123470
[TBL] [Abstract][Full Text] [Related]
6. Construction of a Novel DNA Vaccine Candidate Encoding an HspX-PPE44-EsxV Fusion Antigen of Mycobacterium tuberculosis.
Moradi B; Sankian M; Amini Y; Meshkat Z
Rep Biochem Mol Biol; 2016 Apr; 4(2):89-97. PubMed ID: 27536702
[TBL] [Abstract][Full Text] [Related]
7. Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine.
Mosavat A; Soleimanpour S; Farsiani H; Sadeghian H; Ghazvini K; Sankian M; Jamehdar SA; Rezaee SA
Infect Genet Evol; 2016 Apr; 39():163-172. PubMed ID: 26835592
[TBL] [Abstract][Full Text] [Related]
8. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
9. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
[TBL] [Abstract][Full Text] [Related]
10. Cationic DDA/TDB liposome as a mucosal vaccine adjuvant for uptake by dendritic cells in vitro induces potent humoural immunity.
Qu W; Li N; Yu R; Zuo W; Fu T; Fei W; Hou Y; Liu Y; Yang J
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):852-860. PubMed ID: 29447484
[TBL] [Abstract][Full Text] [Related]
11. APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice.
Soleimanpour S; Farsiani H; Mosavat A; Ghazvini K; Eydgahi MR; Sankian M; Sadeghian H; Meshkat Z; Rezaee SA
Appl Microbiol Biotechnol; 2015 Dec; 99(24):10467-80. PubMed ID: 26373723
[TBL] [Abstract][Full Text] [Related]
12. Heterologous Expression, Purification, and Characterization of the HspX, Ppe44, and EsxV Proteins of
Amini Y; Tafaghodi M; Amel Jamehdar S; Meshkat Z; Moradi B; Sankian M
Rep Biochem Mol Biol; 2018 Apr; 6(2):125-130. PubMed ID: 29765994
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.
Yousefi Avarvand A; Meshkat Z; Khademi F; Tafaghodi M
Microb Pathog; 2021 May; 154():104842. PubMed ID: 33762199
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Triple Fragment Vaccine HSPX (
Valizadeh A; Khosravi A; Sedighian H; Behzadi E; Gholami Parizad E; Imani Fooladi AA
Iran J Pathol; 2022; 17(3):303-313. PubMed ID: 36247511
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the immunogenicity of a
Yousefi Avarvand A; Meshkat Z; Khademi F; Aryan E; Sankian M; Tafaghodi M
Iran J Basic Med Sci; 2024; 27(1):24-30. PubMed ID: 38164481
[TBL] [Abstract][Full Text] [Related]
16. Enhancing immunogenicity of novel multistage subunit vaccine of
Khademi F; Yousefi A; Derakhshan M; Najafi A; Tafaghodi M
Iran J Basic Med Sci; 2019 Aug; 22(8):893-900. PubMed ID: 31579445
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses.
Henriksen-Lacey M; Christensen D; Bramwell VW; Lindenstrøm T; Agger EM; Andersen P; Perrie Y
Mol Pharm; 2011 Feb; 8(1):153-61. PubMed ID: 21117621
[TBL] [Abstract][Full Text] [Related]
18. Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
Hao L; Wu Y; Zhang Y; Zhou Z; Lei Q; Ullah N; Banga Ndzouboukou JL; Lin X; Fan X
Front Immunol; 2020; 11():575504. PubMed ID: 33117374
[TBL] [Abstract][Full Text] [Related]
19. Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel Mycobacterium tuberculosis fusion protein: a multivariate analysis study.
Kastner E; Hussain MJ; Bramwell VW; Christensen D; Perrie Y
J Pharm Pharmacol; 2015 Mar; 67(3):450-63. PubMed ID: 25677402
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC).
Lew MH; Norazmi MN; Tye GJ
Mol Immunol; 2020 Jan; 117():54-64. PubMed ID: 31739193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
